Prognostic Factors in Esophageal Cancer Management

Prognosis in esophageal cancer is influenced by a constellation of clinical, pathological and emerging biomarker factors. Traditional staging based on tumour depth and nodal involvement remains the cornerstone of risk stratification, yet histological features such as lymphovascular invasion, perineural invasion and resection margin status provide additional granularity. Inflammatory markers and systemic indices have shown independent associations with survival, while molecular profiling and circulating biomarkers are under evaluation for personalised risk assessment. Advances in imaging and computational analysis have led to radiomics approaches that extract quantitative features from preoperative scans, enabling prediction of adverse histological findings. Optimal management relies on integration of these prognostic factors into multidisciplinary decision‐making, guiding neoadjuvant strategies, surgical planning and postoperative surveillance. Centralisation of care and standardisation of pathological assessment are critical to improving outcome consistency across institutions worldwide.

Research from Nature Portfolio

Recent studies have refined the understanding of perineural invasion as a dynamic process in squamous cell carcinoma. Detailed pathological classification into early and advanced nerve involvement revealed that higher grades correlate with diminished disease‐free and disease‐specific survival. Improved detection using immunohistochemical staining highlighted nerve pathways as conduits for local recurrence. Functional assays demonstrated tumour cell migration along nerve fibres, confirming perineural spread as an independent predictor of poor outcome. These findings underscore the need to incorporate nerve invasion grading into routine pathology reports and consider adjuvant strategies targeting neural microenvironments.

Prognostic Factors in Esophageal Cancer Management publication trend

The graph below shows the total number of articles in prognostic factors in esophageal cancer management across all publications each year (not limited to Nature Index journals).

Technical terms

Perineural invasion (PNI): Tumour cell infiltration along nerve sheaths, associated with higher recurrence risk.

Lymphovascular invasion (LVI): Presence of cancer cells within lymphatic or blood vessels, indicating a route for metastasis.

Tumour‐associated lymphatic vessel density (LVD): Measure of lymphatic channels in tumour microenvironment, correlated with survival outcomes.

Radiomics: Extraction of high‐dimensional quantitative features from medical imaging to predict pathological or clinical endpoints.

References

1. Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysis. Frontiers in Immunology (2024).
2. Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results From the Dutch Upper GI Cancer Audit. Annals of Surgery (2023).
3. Computed tomography-based radiomics nomogram for prediction of lympho-vascular and perineural invasion in esophageal squamous cell cancer patients: a retrospective cohort study. Cancer Imaging (2024).
4. Prognosis and Progression of ESCC Patients with Perineural Invasion. Scientific Reports (2017).